Have we found how to identify candidates for thrombolysis among normotensive patients with acute pulmonary embolism?
نویسنده
چکیده
Acute pulmonary embolism (PE) results in a wide spectrum of haemodynamic compromise and in hospital PE-related mortality. It is generally accepted that haemodynamically unstable patients with systolic blood pressure <90 mmHg at presentation form a high-risk group (∼5% of all PE patients), with short-term mortality exceeding 15%. They require urgent primary revascularisation performed mostly with systemic thrombolysis. In contrast, only a few patients without shock or hypotension are at risk of an adverse early outcome [1]. Thus, clinically stable, non-high risk patients require further risk stratification in order to optimise their management, including selection of the therapeutic strategy and the duration of the hospitalisation. Current European Society of Cardiology (ESC) guidelines introduced the simplified Pulmonary Embolism Severity Index (sPESI) [2], used for identification of the low-risk group [1]. Patients with sPESI of 0 are at the “benign” end of the risk spectrum; mostly, they have uncomplicated clinical courses and are candidates for very short hospitalisation or can even be managed as outpatients without any further risk stratification.
منابع مشابه
Prognostic Impact of Thrombolysis in Myocardial Infarction Risk Index on Hospitalization Mortality of Patient with Acute Pulmonary Embolism
Introduction: Acute pulmonary embolism (PE) is one of the deadly cardiovascular diseases. One of the indexes proposed in these patients for risk stratification is the Thrombolysis in Myocardial Infarction (TIMI) risk index (TRI), which includes three parameters of systolic blood pressure, age, and heart rate. This study aimed to evaluate the predictive value of TRI on in-hospit...
متن کاملSingle-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial
Background In acute pulmonary embolism (PE), overt right ventricular (RV) failure with cardiogenic shock indicates a poor prognosis. However, normotensive patients with acute RV dysfunction on echocardiography or computed tomography and with myocardial troponin elevation may also have an adverse outcome. Thrombolysis rapidly reverses RV pressure overload in PE, but it remains unclear whether it...
متن کاملPotential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectives.
Submassive (intermediate risk) pulmonary embolism (PE) continues to be a significantly morbid disease process that remains unrecognized, inadequately risk stratified and suboptimally treated. Appropriate early clinical and imaging-based risk stratification represents the cornerstone for adequate therapeutic decision making, particularly for the selection of candidates who may benefit the most f...
متن کاملPulmonary embolism: treatment of the acute episode.
The prognosis of acute pulmonary embolism (PE) is mainly related to the clinical presentation and circulatory state of the patient: the therapeutic strategy is consequently different, ranging from an aggressive treatment in patients in life-threatening clinical conditions to a "stabilization" treatment in those hemodynamically stable. Since the majority of PE patients are clinically stable, a w...
متن کاملThrombolysis for pulmonary embolism: Past, present and future.
Patients with high-risk pulmonary embolism (PE), i.e. those with shock or hypotension at presentation, are at high risk of in-hospital death, particularly during the first hours after admission. A meta-analysis of trials which included haemodynamically compromised patients indicated that thrombolytic treatment significantly reduces the rate of in-hospital death or PE recurrence. Therefore, thro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The European respiratory journal
دوره 47 4 شماره
صفحات -
تاریخ انتشار 2016